StudyRareStudyRare

Increased nuchal translucency and cystic hygroma

Log in to star

Last updated Nov 9, 2026

Log in to add personal notes on this page.

Nuchal translucency (NT) is the fluid-filled space under the skin at the back of the fetal neck, measured on a mid-sagittal view with the neck neutral, at 11 to 14 weeks. ACOG gives 10 0/7 to 13 6/7 weeks and a crown-rump length of about 45 mm (38 mm at some laboratories) to 84 mm. It is the ultrasound half of combined first-trimester screening. Undermeasuring by 0.5 mm cuts sensitivity by 18%.

Three cutoffs:

  • 3.0 mm or more, or above the 99th centile for crown-rump length: ACOG's definition of enlarged. Some centers use 2.5 mm.
  • Above the 95th centile: the lower cutoff in risk tables; it depends on crown-rump length.
  • 3.5 mm or more (above the 99th centile): once aneuploidy is excluded, the risk of an adverse outcome starts to climb here, and it is the threshold for a fetal echocardiogram.

Cystic hygroma is the larger lymphatic form: a fluid-filled cavity at the back of the neck, often septated, that can extend down the length of the fetus. Sources put it above 5 to 6 mm, in either trimester.

  1. How big is it? The chance of a chromosome abnormality is about 7% from the 95th centile to 3.4 mm, 20% at 3.5 to 4.4 mm, 45% at 4.5 to 5.4 mm, 50% at 5.5 to 6.4 mm, and 70% to 75% at 6.5 mm and above. The mix shifts with size: trisomy 21 is two thirds of the abnormal results at the low end, while 45,X rises to 70% of them above 11.5 mm.
  2. Are the chromosomes normal? Karyotype and microarray first; the single-gene differential opens after.
  3. What does the 18 to 22 week scan show? A resolved NT with normal anatomy and a normal heart is the reassurance.

Other first-trimester markers travel with NT: absent nasal bone, tricuspid regurgitation, and a reversed a-wave in the ductus venosus. The reversed a-wave is seen in about two thirds of fetuses with trisomy 21 and 3% of euploid fetuses, and it also raises the chance of a heart defect.

Chromosome abnormalities

  • Trisomy 21: the most common abnormality at all but the largest measurements, and the leading aneuploidy with a first-trimester cystic hygroma.
  • Trisomy 18 and trisomy 13: NT is rarely the only finding. Look for early growth restriction, heart defects, and holoprosencephaly in trisomy 13.
  • Turner syndrome (45,X): cystic hygroma is the hallmark, more often in the second trimester, with nonimmune hydrops, coarctation, and horseshoe kidney.
  • Triploidy, plus unbalanced translocations, marker chromosomes, mosaicism, and copy number variants.

Normal chromosomes: the heart

Normal chromosomes: RASopathies

  • Noonan syndrome: autosomal dominant, often de novo; PTPN11 in about half, also SOS1, RAF1, RIT1, KRAS. About 15% of euploid fetuses with a large NT and 9% to 17% of euploid cystic hygromas. Polyhydramnios may accompany the NT; pulmonary stenosis and hypertrophic cardiomyopathy are the usual heart findings.
  • Cardiofaciocutaneous syndrome and the other RASopathies: CFC brings fetal edema and polyhydramnios (BRAF, MAP2K1, MAP2K2, KRAS).

Normal chromosomes: other causes

  • Skeletal dysplasias.
  • Multiple pterygium syndrome.
  • Abdominal wall defects, diaphragmatic hernia, congenital infection, and metabolic and hematologic disorders.
  • "Septated cystic hygroma on the second-trimester scan" is 45,X until proven otherwise. In the first trimester, trisomy 21 leads.
  • "Increased NT, normal microarray, then pulmonary stenosis or polyhydramnios" is Noonan syndrome. Examine both parents: the adult face is subtler, and about half of cases have a family history.
  • A shrinking NT has not excluded aneuploidy. Nuchal edema can resolve in a chromosomally abnormal fetus, and hygromas regress in about 10% of aneuploid cases.
  • One enlarged NT in a size-discordant monochorionic twin pair can be early twin-twin transfusion syndrome rather than aneuploidy.
  • NT versus nuchal fold. The nuchal fold is a second-trimester soft-tissue measurement, 6 mm or more from the outer occipital bone to the outer skin, and belongs with the second-trimester soft markers.
  1. Genetic counseling and diagnostic testing: CVS or amniocentesis. A low-risk cell-free DNA result does not close the question: the differential includes copy number variants and single-gene disorders.
  2. Karyotype and chromosomal microarray. Microarray finds a significant variant in about 6% of fetuses with a structural finding and a normal karyotype.
  3. Detailed anatomy scan at 18 to 22 weeks and a fetal echocardiogram (offered for any enlarged NT with normal chromosomes, recommended at 3.5 mm or more).
  4. RASopathy panel when the microarray is normal, then exome, ideally as a trio (8% to 10% yield after a normal karyotype and microarray).
  • Size drives everything. Among euploid fetuses, a live birth without defects falls from 92% at the 95th centile to 3.4 mm to 20% at 6.5 mm or more.
  • Normal chromosomes, a resolved NT, and a normal detailed scan and heart: better than a 95% chance of no major abnormality. One large follow-up found a sixfold relative rise in intellectual disability above the 99th centile, under 1% absolute.
  • Cystic hygroma is 50% to 70% aneuploid and carries a worse prognosis than increased NT even with normal chromosomes, though 89% of euploid hygromas without other anomalies or hydrops were normal at follow-up in one series.